global-alert
global messaging alerts

Press Releases

    2024

  • May 14, 2024

    ApiJect Appoints Joseph Wojcik, MBA, PMP Senior Director of Pharmaceutical Development Services

  • May 6, 2024

    Celebrating the 40th Anniversary of the Invention of the K-1 Auto-Disabled Syringe

  • February 28, 2024

    ApiJect Announces Proof-of-Concept in Blow-Fill-Seal at Orlando Technology Development Center – Opportunity to “Test Drive” ApiJect Technology –

    2023

  • October 3, 2023

    ApiJect Bolsters Global Health Team with Esteemed Anthropologist and Leading Expert on Vaccine Hesitancy, Dr. Heidi Larson, as Senior Advisor

  • September 28, 2023

    Single-Dose Prefilled ApiJect Injector is Finalist in CPHI Pharma Awards 2023

  • March 14, 2023

    ApiJect Announces Appointment of Key Pharmaceutical and Device Professionals

    2022

  • September 15, 2022

    ApiLabs, R&D sister company to ApiJect, launches its Field Research Network

  • May 18, 2022

    ApiJect Systems Announces Investment by Royalty Pharma and Jefferies

  • April 22, 2022

    ApiJect Announces the Opening of the ApiJect Technology Development Center

  • April 4, 2022

    ApiJect Systems Announces Russell “Bo” Kowalczyk Joins Company

  • March 30, 2022

    ApiJect Announces Edward Kelley, PhD, as Chief Global Health Officer

  • February 1, 2022

    ApiJect Announces Molly Weaver, PhD, as New Chief Technology Officer

    2021

  • December 9, 2021

    Fareva and ApiJect Sign a Licensing Agreement

  • October 12, 2021

    ApiJect Chief Global Health Officer Ed Kelley to Participate in INTERPHEX Live

  • April 21, 2021

    ApiJect Issues Statement on NBC Digital News Story

    2020

  • May 12, 2020

    ApiJect Awarded HHS-DoD Contract of $138MM

Social media & sharing icons powered by UltimatelySocial
Twitter
YouTube
YouTube
LinkedIn
LinkedIn